Send your comments and tips to firstname.lastname@example.org
Beth Israel Deaconess Medical Ctr.
Boston Medical Center
Brigham and Women's Hospital
Cambridge Health Alliance
Caritas St. Elizabeth's Medical Ctr.
Children's Hospital Boston
Dana-Farber Cancer Institute
Joslin Diabetes Center
Mass. General Hospital
Mass. Health Law
New England Baptist Hospital
Short White Coat
Tufts-New England Medical Center
UMass Memorial Medical Center
University of Massachusetts
VA Medical Centers
A Healthy Blog
Running A Hospital
Nature Network Boston
SciBos - Corie Lok's blog
Nurse at small
Dr. Gwenn Is In
Healthy Children blog
Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
Short White Coat blogger Ishani Ganguli
Short White Coat blogger Jennifer Srygley
Friday, March 30, 2007
Today's Globe: stem cell curb, HHS resignation, anesthesia for children, insurer rates, Vioxx-like drug, cancer reality
Governor Deval Patrick will announce this morning that he wants the Department of Public Health to reverse restrictions on stem cell research imposed by his predecessor, according to an administration official with direct knowledge of the governor's intentions.
Dr. Eric Keroack, the head of the federal Health and Human Services Department office responsible for providing women with access to contraceptives and counseling to prevent pregnancy resigned unexpectedly yesterday after Medicaid officials took action against him in Massachusetts.
Anesthesia can be harmful to the developing brain, Food and Drug Administration studies on animals suggest, raising concerns about potential risks in putting young children under for surgery.
In a second round of bidding earlier this year, monthly premiums for the four low-cost health insurance plans to be offered in the Boston area were cut by an average of 8 percent, according to records the Globe obtained from the Commonwealth Health Insurance Connector Authority in response to a Freedom of Information Act request.
Some analysts are scratching their heads at the move Merck & Co. is planning: The drug maker wants to sell a new painkiller that is just like Vioxx, the blockbuster drug it pulled from the market in 2004 because the treatment doubled heart risks.
All people need hope: hope for a good day today, hope for a normal life, and possibly hope for a cure, Dr. Darshak Sanghavi writes in an op-ed essay in light of cancer coming back for Elizabeth Edwards and Tony Snow. But he says that brings us to a painful and necessary question: Is there such a thing as false hope?